| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1042564548 |
| P356 | DOI | 10.1007/S002130050667 |
| P698 | PubMed publication ID | 9725745 |
| P2093 | author name string | B B Simon | |
| E D Levin | |||
| P433 | issue | 3-4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acetylcholine | Q180623 |
| P304 | page(s) | 217-30 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Nicotinic acetylcholine involvement in cognitive function in animals | |
| P478 | volume | 138 |
| Q44522002 | A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease |
| Q43518186 | A proposed pathological model in the hippocampus of subjects with schizophrenia |
| Q44070062 | A specific anti-aggressive effect of repeatedly administered lobeline |
| Q46477474 | A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana |
| Q43857751 | A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task |
| Q48458709 | A unifying hypothesis of Alzheimer's disease. III. Risk factors |
| Q34290304 | AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors |
| Q36956975 | Abnormal social behavior in nicotinic acetylcholine receptor β4 subunit-null mice |
| Q35840916 | Acetylcholine dynamically controls spatial integration in marmoset primary visual cortex |
| Q37070299 | Acetylcholine receptors in dementia and mild cognitive impairment. |
| Q35975080 | Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex. |
| Q50571393 | Activation of matrix metalloproteinase in dorsal hippocampus drives improvement in spatial working memory after intra-VTA nicotine infusion in rats. |
| Q43543816 | Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus. |
| Q42676081 | Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial |
| Q44452279 | Adolescent-onset nicotine self-administration modeled in female rats |
| Q44831655 | Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression |
| Q52169092 | Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease. |
| Q24629740 | Allosteric modulator Desformylflustrabromine relieves the inhibition of α2β2 and α4β2 nicotinic acetylcholine receptors by β-amyloid(1-42) peptide |
| Q35182101 | Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors |
| Q34002795 | Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease |
| Q34327777 | Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia |
| Q34043452 | Alpha2 nicotine receptors function as a molecular switch to continuously excite a subset of interneurons in rat hippocampal circuits |
| Q33953018 | Alterations of cortical pyramidal neurons in mice lacking high-affinity nicotinic receptors |
| Q39392548 | Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. |
| Q34160761 | Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies |
| Q28070135 | Alzheimer's disease: Targeting the Cholinergic System |
| Q34750579 | Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: a minireview |
| Q33392254 | Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease |
| Q34814145 | Amyloid-β as a Modulator of Synaptic Plasticity |
| Q36966660 | Amyloid-β peptide: Dr. Jekyll or Mr. Hyde? |
| Q34513218 | Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models |
| Q37152324 | Association between smoking and retrospectively reported attention-deficit/hyperactivity disorder symptoms in a large sample of new mothers |
| Q34023931 | Attention as a target of intoxication: insights and methods from studies of drug abuse |
| Q36673034 | Attention-deficit/hyperactivity disorder: neurophysiology, information processing, arousal and drug development. |
| Q41961835 | Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus. |
| Q33837663 | Both a nicotinic single nucleotide polymorphism (SNP) and a noradrenergic SNP modulate working memory performance when attention is manipulated |
| Q46979193 | Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana |
| Q28579410 | Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways |
| Q42630768 | Ca(2+)-sensitive inhibition by Pb(2+) of alpha7-containing nicotinic acetylcholine receptors in hippocampal neurons. |
| Q90132133 | Cell class-specific modulation of attentional signals by acetylcholine in macaque frontal eye field |
| Q40413207 | Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells |
| Q27319426 | Central Thalamic Deep-Brain Stimulation Alters Striatal-Thalamic Connectivity in Cognitive Neural Behavior |
| Q34002742 | Central nicotinic receptors, neurotrophic factors and neuroprotection |
| Q33273397 | Central nicotinic receptors: structure, function, ligands, and therapeutic potential. |
| Q43921716 | Cholinergic blockade impairs performance in operant DNMTP in two inbred strains of mice |
| Q37217895 | Cholinergic components of frontal lobe function and dysfunction |
| Q45254534 | Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect |
| Q44905438 | Cholinergic elements in the zebrafish central nervous system: Histochemical and immunohistochemical analysis |
| Q44894391 | Cholinergic enhancement of frontal lobe activity in mild cognitive impairment |
| Q47734850 | Cholinergic innervation of the frontal cortex: differences among humans, chimpanzees, and macaque monkeys |
| Q42412784 | Cholinergic modulation of Pavlovian fear conditioning in rats: differential effects of intrahippocampal infusion of mecamylamine and methyllycaconitine |
| Q36501617 | Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. |
| Q44556491 | Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex. |
| Q44611321 | Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment |
| Q35607538 | Clinical pharmacokinetics of galantamine |
| Q48518639 | Clock mutant mice with Jcl/ICR background shows an impaired learning ability in water maze, but not in passive avoidance, at the beginning of dark phase. |
| Q41842706 | Coantagonism of glutamate receptors and nicotinic acetylcholinergic receptors disrupts fear conditioning and latent inhibition of fear conditioning |
| Q46915060 | Coexposure of neonatal mice to a flame retardant PBDE 99 (2,2',4,4',5-pentabromodiphenyl ether) and methyl mercury enhances developmental neurotoxic defects |
| Q37376724 | Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics |
| Q44407158 | Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors |
| Q30396291 | Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking |
| Q32077222 | Cognitive effects of nicotine |
| Q44525587 | Cognitive effects of nicotine in humans: an fMRI study |
| Q30474904 | Cognitive effects of nicotine: genetic moderators |
| Q46726459 | Cognitive performance of healthy young rats following chronic donepezil administration |
| Q36052639 | Combined effects of marijuana and nicotine on memory performance and hippocampal volume |
| Q44412242 | Cooperation between memory systems: Acetylcholine release in the amygdala correlates positively with performance on a hippocampus-dependent task |
| Q47903798 | Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome |
| Q24800530 | Current pharmacologic options for patients with Alzheimer's disease |
| Q42183318 | D-amphetamine, nicotine, and haloperidol produce similar disruptions in spatial and nonspatial temporal discrimination procedures. |
| Q37389482 | DRD2-related TaqIA polymorphism modulates motivation to smoke. |
| Q33599626 | DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory |
| Q45037384 | Deficits in a sustained attention task following nicotine withdrawal in rats. |
| Q52023315 | Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats. |
| Q34437992 | Depression and nicotine: preclinical and clinical evidence for common mechanisms |
| Q52027607 | Development of nicotinic drug therapy for cognitive disorders. |
| Q43833022 | Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice. |
| Q73302989 | Diminution of nicotinic receptor alpha 3 subunit mRNA expression in aged rat brain |
| Q59649729 | Distribution of choline acetyltransferase (ChAT) immunoreactivity in the brain of the adult trout and tract-tracing observations on the connections of the nuclei of the isthmus |
| Q33751420 | Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area |
| Q26748728 | Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders |
| Q48963518 | ERK1/2 protein and mRNA levels in human blood are linked to smoking behavior |
| Q41822825 | Effect of acute nicotine administration on striatal dopamine output and metabolism in rats kept at different ambient temperatures |
| Q52144163 | Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. |
| Q28362149 | Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial |
| Q43916557 | Effects of chronic nicotine administration on nitric oxide synthase expression and activity in rat brain |
| Q44008403 | Effects of cigarette smoke on the immune system |
| Q44448608 | Effects of imidacloprid metabolites on habituation in honeybees suggest the existence of two subtypes of nicotinic receptors differentially expressed during adult development |
| Q37231098 | Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies |
| Q44274445 | Effects of nicotine and dietary salt on a learned blood pressure response in Dahl-S rats |
| Q36899798 | Effects of nicotine on emotional distraction of attentional orienting: evidence of possible moderation by dopamine type 2 receptor genotype. |
| Q44551686 | Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats |
| Q37511387 | Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans |
| Q42687180 | Effects of the histamine H₃ receptor antagonist ABT-239 on cognition and nicotine-induced memory enhancement in mice |
| Q30435496 | Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia |
| Q34655353 | Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen |
| Q30491331 | Elevations of endogenous kynurenic acid produce spatial working memory deficits |
| Q35946508 | Endogenously released ACh and exogenous nicotine differentially facilitate long-term potentiation induction in the hippocampal CA1 region of mice |
| Q43892728 | Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase. |
| Q36295731 | Estimating binding affinities of the nicotinic receptor for low-efficacy ligands using mixtures of agonists and two-dimensional concentration-response relationships |
| Q90482443 | Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease |
| Q53426928 | Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests. |
| Q92964504 | Exploring the efficacy of natural products in alleviating Alzheimer's disease |
| Q40658070 | Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 properties |
| Q28594253 | Fear conditioning and latent inhibition in mice lacking the high affinity subclass of nicotinic acetylcholine receptors in the brain |
| Q28288721 | From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research |
| Q35104827 | From smoking to cancers: novel targets to neuronal nicotinic acetylcholine receptors |
| Q35598387 | Functional and molecular characterization of neuronal nicotinic ACh receptors in rat hippocampal interneurons |
| Q48565611 | Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors |
| Q28205980 | Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR |
| Q32077293 | Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease |
| Q44600262 | Gene expression profiling following chronic NMDA receptor blockade‐induced learning deficits in rats |
| Q46397571 | Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population |
| Q38616570 | Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis |
| Q30432387 | Genome-wide expression analysis reveals diverse effects of acute nicotine exposure on neuronal function-related genes and pathways |
| Q36560437 | Guidelines on nicotine dose selection for in vivo research. |
| Q43942893 | Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory |
| Q30480193 | Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits |
| Q42505578 | Histochemical study of acute and chronic intraperitoneal nicotine effects on several glycolytic and Krebs cycle dehydrogenase activities in the frontoparietal cortex and subcortical nuclei of the rat brain |
| Q28477118 | Identification of a negative allosteric site on human α4β2 and α3β4 neuronal nicotinic acetylcholine receptors |
| Q46693571 | Immunohistochemical increase in cyclooxygenase-2 without apoptosis in different brain areas of subchronic nicotine- and D-amphetamine-treated rats |
| Q37125488 | Impaired cognition and attention in adults: pharmacological management strategies |
| Q35031640 | Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease |
| Q33565245 | Improved Cholinergic Transmission is Detrimental to Behavioural Plasticity in Honeybees (Apis mellifera). |
| Q38393705 | Improvement of contextual memory by S 24795 in aged mice: comparison with memantine |
| Q44579179 | In vivo pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies |
| Q41737758 | Inactivation of alpha7 ACh receptors and activation of non-alpha7 ACh receptors both contribute to long term potentiation induction in the hippocampal CA1 region. |
| Q44374006 | Increase of hippocampal acetylcholine release at the onset of dark phase is suppressed in a mutant mice model of evening-type individuals. |
| Q45183292 | Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients |
| Q36913081 | Influence of acute or chronic calcium channel antagonists on the acquisition and consolidation of memory and nicotine-induced cognitive effects in mice |
| Q46011252 | Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus maze. |
| Q35892576 | Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia |
| Q47345076 | Influence of nicotine on doxorubicin and cyclophosphamide combination treatment-induced spatial cognitive impairment and anxiety-like behavior in rats |
| Q35044605 | Inhibition of neuronal nicotinic acetylcholine receptors by the abused solvent, toluene |
| Q43977393 | Inhibition of skeletal muscle nicotinic receptors by the atypical antipsychotic clozapine |
| Q48462465 | Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults |
| Q41869576 | Investigating the synchronization of hippocampal neural network in response to acute nicotine exposure |
| Q50770547 | Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice. |
| Q44405503 | Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats. |
| Q44423538 | Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta |
| Q41755194 | Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization |
| Q47976307 | Low-dose nicotine facilitates spatial memory in ApoE-knockout mice in the radial arm maze |
| Q24647069 | Mammalian nicotinic acetylcholine receptors: from structure to function |
| Q44111435 | Mecamylamine blocks enhancement of reference memory but not working memory produced by post-training injection of nicotine in rats tested on the radial arm maze |
| Q52147631 | Mechanisms of Nicotinic Modulation of Glutamatergic Neuroplasticity in Humans. |
| Q43752065 | Memory improving actions of gabapentin in mice: possible involvement of central muscarinic cholinergic mechanism |
| Q50965908 | Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test. |
| Q41656051 | Moderation of nicotine effects on covert orienting of attention tasks by poor placebo performance and cue validity. |
| Q48559497 | Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study |
| Q46816855 | Neonatal nicotine exposure impairs nicotinic enhancement of central auditory processing and auditory learning in adult rats |
| Q42506980 | Neuroanatomical organization of the cholinergic system in the central nervous system of a basal actinopterygian fish, the senegal bichir Polypterus senegalus |
| Q30462470 | Neurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career. |
| Q34329836 | Neurogenetic effects on cognition in aging brains: a window of opportunity for intervention? |
| Q36977796 | Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback |
| Q53449644 | Neuromodulation of Attention. |
| Q44854644 | Neuronal nicotinic acetylcholine receptors as drug targets. |
| Q37473457 | Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders |
| Q36606396 | Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q53237072 | Neuronal nicotinic receptors in synaptic functions in humans and rats: physiological and clinical relevance. |
| Q28141480 | Neuronal nicotinic receptors in the human brain |
| Q43147413 | Neuropsychological function in patients with a single gene mutation associated with autosomal dominant nocturnal frontal lobe epilepsy |
| Q38544385 | Neurotoxicants, Micronutrients, and Social Environments: Individual and Combined Effects on Children's Development |
| Q48049078 | Nicotine Significantly Improves Chronic Stress-Induced Impairments of Cognition and Synaptic Plasticity in Mice |
| Q43543811 | Nicotine accelerates reversal of long-term potentiation and enhances long-term depression in the rat hippocampal CA1 region |
| Q44609220 | Nicotine as a signal for the presence or absence of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats |
| Q44193624 | Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro |
| Q37210533 | Nicotine does not enhance discrimination performance in a temporal bisection procedure |
| Q42434162 | Nicotine does not produce state-dependent effects on learning in a Pavlovian appetitive goal tracking task with rats. |
| Q46419456 | Nicotine effects on learning in zebrafish: the role of dopaminergic systems |
| Q46882612 | Nicotine effects on mismatch negativity in nonsmoking schizophrenic patients |
| Q52169195 | Nicotine enhances stimulus detection performance of middle- and old-aged rats: a longitudinal study. |
| Q46348901 | Nicotine exposure in vivo induces long-lasting enhancement of NMDA receptor-mediated currents in the hippocampus. |
| Q33781362 | Nicotine facilitates long-term potentiation induction in oriens-lacunosum moleculare cells via Ca2+ entry through non-alpha7 nicotinic acetylcholine receptors |
| Q44784226 | Nicotine improves delayed recognition in schizophrenic patients |
| Q44768739 | Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor |
| Q44317337 | Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex |
| Q48031081 | Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation. |
| Q41731213 | Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region. |
| Q34490857 | Nicotine uses neuron-glia communication to enhance hippocampal synaptic transmission and long-term memory. |
| Q34655902 | Nicotine's effect on neural and cognitive functioning in an aging population |
| Q34959810 | Nicotine's oxidative and antioxidant properties in CNS. |
| Q44026242 | Nicotine-alcohol interactions and cognitive function in rats |
| Q38299405 | Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala. |
| Q43794658 | Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells |
| Q48127922 | Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices |
| Q33894536 | Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function |
| Q37485939 | Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system |
| Q43977389 | Nicotinic acetylcholine receptor-mediated release of [3H]norepinephrine from developing and adult rat hippocampus: direct and indirect mechanisms |
| Q37041678 | Nicotinic acetylcholine receptor-mediated responses in medial vestibular and prepositus hypoglossi nuclei neurons showing distinct neurotransmitter phenotypes |
| Q46575250 | Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation. |
| Q48135473 | Nicotinic acetylcholine receptors contribute to learning-induced metaplasticity in the hippocampus |
| Q34459004 | Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization |
| Q44536411 | Nicotinic effects on excitatory field potentials recorded from the immature CA3 area of rat hippocampal slices |
| Q30465509 | Nicotinic filtering of sensory processing in auditory cortex |
| Q30372351 | Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders |
| Q33830478 | Nicotinic mechanisms influencing synaptic plasticity in the hippocampus |
| Q44317827 | Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala |
| Q30993631 | Nicotinic modulation of neuronal networks: from receptors to cognition |
| Q37533310 | Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits |
| Q30488616 | Nicotinic modulation of tone-evoked responses in auditory cortex reflects the strength of prior auditory learning |
| Q51424143 | Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. |
| Q36564840 | Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms |
| Q24532028 | Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders |
| Q37347201 | Nicotinic receptors containing the alpha7 subunit: a model for rational drug design |
| Q33763401 | Nicotinic receptors in the brain: correlating physiology with function |
| Q34002775 | Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease. |
| Q51974303 | Non-associative learning in larval zebrafish. |
| Q37129328 | Nonsynaptic chemical transmission through nicotinic acetylcholine receptors |
| Q47273268 | Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi |
| Q34411638 | Normal genetic variation, cognition, and aging |
| Q95661003 | Opposing effects of acute and repeated nicotine exposure on boldness in zebrafish |
| Q42492793 | Organization of the cholinergic systems in the brain of two lungfishes, Protopterus dolloi and Neoceratodus forsteri. |
| Q36229920 | Patterns of Tobacco Consumption among Indian Men with Schizophrenia Compared to Their Male Siblings |
| Q27008213 | Paying attention to smell: cholinergic signaling in the olfactory bulb |
| Q28588757 | Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory |
| Q57084439 | Persistence of nicotinic agonist RJR 2403-induced working memory improvement in rats |
| Q43632861 | Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine |
| Q37378691 | Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders |
| Q35886492 | Physiology and pathology of calcium signaling in the brain |
| Q28592777 | Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus |
| Q35039565 | Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats |
| Q46692798 | Post-training intrahippocampal infusion of nicotine prevents spatial memory retention deficits induced by the cyclo-oxygenase-2-specific inhibitor celecoxib in rats. |
| Q42469466 | Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat. |
| Q52023506 | Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. |
| Q44464113 | Psychoactive drugs and pilot performance: a comparison of nicotine, donepezil, and alcohol effects |
| Q35544975 | Realistic Expectations: The Management of Severe Alzheimer Disease |
| Q46808065 | Region-specific effects of nicotine on brain activity: a pharmacological MRI study in the drug-naïve rat. |
| Q49151499 | Regulation of the sensitivity of acetylcholine receptors to nicotine in rat habenula neurons |
| Q45248995 | Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions |
| Q44554999 | Role of central cholinergic receptor sub-types in spatial working memory: a five-arm maze task in mice provides evidence for a functional role of nicotinic receptors in mediating trace access processes |
| Q34390062 | Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish. |
| Q37356496 | Role of the cholinergic system in the pathology and treatment of schizophrenia. |
| Q34561031 | SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. |
| Q46022887 | Schizophrenia and memory impairment: evidence for a neurocognitive subtype. |
| Q34002872 | Schizophrenia and the alpha7 nicotinic acetylcholine receptor |
| Q42580171 | Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats |
| Q46016940 | Sexual function in adult male rats after prenatal modulation of the cholinergic system. |
| Q48827718 | Short latency afferent inhibition differs among the subtypes of mild cognitive impairment |
| Q34297771 | Signaling and gene expression in the neuron-glia unit during brain function and dysfunction: Holger Hydén in memoriam |
| Q96834102 | Signature-based approaches for informed drug repurposing: targeting CNS disorders |
| Q34989464 | Similarities between Alzheimer's disease and vascular dementia |
| Q28215784 | Smoking and mental illness |
| Q43202785 | Smoking behaviour is associated with expression and phosphorylation of CREB in human buffy coat |
| Q30491841 | Smoking, Genetics and Schizophrenia: Evidence for Self Medication |
| Q34312472 | Specificity of the effect of a nicotinic receptor polymorphism on individual differences in visuospatial attention |
| Q37954123 | Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. |
| Q43994880 | Synaptic vesicle recycling at two classes of release sites in giant nerve terminals of the embryonic chicken ciliary ganglion |
| Q34987300 | Targeting nicotine addiction: the possibility of a therapeutic vaccine. |
| Q48354998 | The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems |
| Q44872673 | The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease. |
| Q42523508 | The effect of nicotine on spiking activity and Ca2+ dynamics of dendritic spines in rat CA1 pyramidal neurons |
| Q33849877 | The effect of scalp point cluster-needling on learning and memory function and neurotransmitter levels in rats with vascular dementia |
| Q30446776 | The effect of withdrawal and intake of nicotine on smokers' ability to ignore distractors in a number parity decision task |
| Q46575771 | The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice |
| Q46605171 | The effects of chronic nicotine on spatial learning and bromodeoxyuridine incorporation into the dentate gyrus of the rat. |
| Q46340006 | The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats |
| Q51790931 | The effects of varenicline on attention and inhibitory control among treatment-seeking smokers. |
| Q28568723 | The epigenetic effect of nicotine on dopamine D1 receptor expression in rat prefrontal cortex |
| Q28709470 | The human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspective |
| Q51363792 | The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. |
| Q36110563 | The rhythm of rest and excess |
| Q42390629 | The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease |
| Q44319015 | The role of cortical cholinergic pre- and post-synaptic receptors in taste memory formation. |
| Q26852620 | The role of neuromodulators in selective attention |
| Q28576908 | The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination |
| Q48451432 | The short term effect of nicotine abstinence on visuospatial working memory in smoking patients with schizophrenia. |
| Q43702735 | Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity |
| Q46713909 | Timing of nicotine effects on learning in zebrafish |
| Q30493072 | Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. |
| Q34079586 | Treatment of Alzheimer's disease: rationale and strategies |
| Q36687594 | Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons. |
| Q35046256 | Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats |
| Q44588494 | Ventral hippocampal NMDA blockade and nicotinic effects on memory function |
| Q73109584 | Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory |
| Q35740911 | Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats |
| Q28572661 | Wnt-7a induces presynaptic colocalization of alpha 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons |
| Q30493208 | Zebrafish: An in vivo model for the study of neurological diseases |
| Q30500484 | alpha7 Nicotinic acetylcholine receptors and temporal memory: synergistic effects of combining prenatal choline and nicotine on reinforcement-induced resetting of an interval clock. |
| Q61314596 | alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus |
| Q30487599 | beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice |
Search more.